Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Australia (ECOS AUS)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Merck Serono Australia Pty Ltd
Information provided by (Responsible Party):
Merck KGaA
ClinicalTrials.gov Identifier:
NCT01309555
First received: March 3, 2011
Last updated: June 16, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2016
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)